Skip to main content
Clinical Trials/IRCT20151228025732N70
IRCT20151228025732N70Recruiting未知

Evaluation of the protective effect of Curcuma Longa against cisplatin induced nephrotoxicity in patients with cancer

Semnan University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Age 18-60 years
  • Confirmation of cancer by a specialist doctor
  • The disease should be such that the use of cisplatin as a treatment is approved by a specialist doctor

Exclusion Criteria

  • The patient has a previous kidney disease (GFR is low from the beginning)
  • Existence of underlying diseases such as diabetes, hypertension, etc. in the patient
  • Increased creatinine indicated for discontinuation of the drug

Investigators

Sponsor
Semnan University of Medical Sciences

Similar Trials